Skip to main content
MedPathMedPath Home
Clinical Trials/NCT01352897
NCT01352897
Completed
Not Applicable

A Registry to Collect Data of Efficacy and Safety Between Rosuvastatin, and Atorvastatin and Simvastatin In Subjects With Type IIa and IIb Hypercholesterolaemia Under Real Clinical Settings

AstraZeneca1 site in 1 country800 target enrollmentAugust 2010
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHypercholesterolaemia

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypercholesterolaemia
Sponsor
AstraZeneca
Enrollment
800
Locations
1
Primary Endpoint
Percentage of patients who maintain US NCEP ATP III LDL-C target goals after long-term therapy
Status
Completed
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSitesSimilar Trials

Overview

Brief Summary

The objective of this follow-up retrospective study is to evaluate the long term efficacy and safety of rosuvastatin in reducing lipid parameters in clinical practice.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
December 2010
Last Updated
14 years ago
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Primary hypercholesterolemia
  • •Subjects from first rosuvastatin Registry study

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Percentage of patients who maintain US NCEP ATP III LDL-C target goals after long-term therapy

Time Frame: Up to 8 years

Secondary Outcomes

  • LDL-cholesterol levels(Up to 8 years)
  • HDL-cholesterol levels(Up to 8 years)
  • Proportion of patients having raised levels of serum CK or ALT(Up to 8 years)

Study Sites (1)

Loading locations...

Similar Trials

Enrolling By Invitation
Not Applicable
Observational Registry for Iltamiocel Compared to Placebo for Urinary Sphincter Repair in Post-surgical Female Stress IncontinenceStress Urinary Incontinence
NCT06743620Cook MyoSite96
Completed
Not Applicable
Retrospective Study of the Safety and Efficacy of Patients With RVO in Subjects Who Completed Parent Study CLS1003-201Macular EdemaRetinal Vein Occlusion
NCT02956330Clearside Biomedical, Inc.20
Enrolling By Invitation
Phase 2
Long-term Follow-Up Study of RGX-314 and Fellow Eye SubstudyNeovascular Age-related Macular DegenerationWet Macular Degeneration
NCT03999801AbbVie865
Unknown
Not Applicable
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMDNeovascular Age-Related Macular Degeneration (nAMD)Gene TherapyAMDWet AMDwAMDnAMD
NCT05210803AbbVie115
Enrolling By Invitation
Not Applicable
Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic RetinopathyDiabetic Retinopathy, DR
NCT05296447AbbVie100